Purchase Order 75N95019P00364
Award Date 6/14/19
Potential Completion Date 12/31/19
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Natick, MA 01760, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Xtal Biostructures Inc., a small business subchapter S corporation, was issued by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). The $97,000 firm-fixed-price purchase order is for protein crystallization and x-ray crystallography services on the Large Tumor Suppressor Kinase 1 (LATS1) protein to support NCATS' preclinical research initiatives. The original sources sought notice was issued as a...
- This federal contract award, valued at $148,110.00, was issued by the National Cancer Institute (an agency of the National Institutes of Health) to Xtal Biostructures Inc., a biotechnology company that specializes in protein crystallization, x-ray crystallography, and biochemical product generation. The contract is for the "GENERATION OF SITE SPECIFIC PHOSPHO-THREONINE PROTEIN STANDARDS FOR USE IN CANCER ASSAYS". This work supports the National Cancer Institute's research efforts. Xtal...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Proteros Biostructures GMBH, a foreign-owned for-profit organization and manufacturer of goods. The contract is for $38,035.00 and is for x-ray structure analyses of eEF1A2 and c-Abl in complex with ligands. The contract was awarded on September 3, 2015 and has a completion date of September 7, 2016....
- This purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $79,400. The contract is for X-ray crystallography studies of ALDH1A2 to crystallize two novel small molecules within the enzyme to assist with structure-based drug design as part of an ongoing medicinal chemistry campaign. Specifically, the contractor will perform X-ray crystallography...
- This is a $120,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract was awarded to Maxcyte, Inc., a commercial cell engineering company, to provide specialized laboratory equipment and technologies such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services to support NIDA's...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Formulatrix, LLC, a foreign-owned for-profit organization. The $97,600.00 contract is for the provision of a Protein Crystallography Screen Builder, an automated laboratory instrument used in biomedical research efforts. Formulatrix, which specializes in laboratory automation solutions, has received multiple prime...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $12,472 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide protein analysis services and equipment. The place of performance is in Potomac, Maryland through October 13, 2023. As part of NIH's efforts to advance translational sciences and support, this award will enable Proteinsimple to...
- <p>This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences, a civilian federal agency, to Helix Biostructures LLC, a self-certified small disadvantaged business. The $24,500.00 contract is for crystallization and structure solution services for biliverdin reductase A. The work is to be performed in Potomac, MD and has an ultimate completion date of March 2, 2025. The contract does not have a set-aside designation.</p>
- This federal contract award was made by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, to prime contractor William Newcomb for $104,505.00 to provide electron microscopy and X-ray crystallographer services. The contract, which does not have a set-aside designation, has a completion date of May 24, 2024. The contract was awarded non-competitively through a pre-solicitation process, as the services were deemed sole-source. This contract supports...
- This is a $199,184 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to the California Institute of Technology (Caltech) for biochemical, biophysical, and in vivo testing of up to 100 compounds. The contract is not set aside and was awarded under a pre-solicitation opportunity that sought a full-service provider to characterize compound-protein interactions using techniques like protein purification, thermal unfolding assays, flow...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) and National Institute on Drug Abuse to Xtal Biostructures, Inc., a biotechnology company that specializes in protein crystallization, x-ray crystallography, and biochemical product services. The $12,500.00 firm fixed price purchase order contract is for Xtal Biostructures to provide protein crystallization, x-ray crystallography, testing, and protein generation services to support research studies, including work on the Large Tumor Suppressor Kinase 1 (LATS1) protein for the NIH's National Center for Advancing Translational Sciences. The contract does not have a set-aside designation.
Generated 5/7/24, 11:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 6/14/19 |